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SUMMARY. The conventional method for preparing chitosan nanoparticles (CS-NPs) leads to the surface
amino groups protonated and unable to link other useful moieties. In this study, we optimized the method
of sodium chloride precipitation our lab established before to produce CS-NPs with surface free amino
groups. The effects of preparation conditions on the size and encapsulation efficiency were examined. As
surface amino groups may exert special effect on the NPs biodistribution, in vivo distribution was investi-
gated after intravenous administration to the mice. The optimized CS-NPs were round with the mean di-
ameter of 257 ± 21 nm. Compared with trans-resveratrol solution, the CS-NPs had longer circulation time
in vivo. The AUC of CS-NPs in liver was 2.29 fold AUC of the solution. This study demonstrates that not
only can the unique CS-NPs be modified to obtain active targeting systems, they are also an excellent can-
didate for liver targeting treatment.
